11/07/2024
6:02 AM | ProQR Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/25/2024
3:07 PM | ProQR Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/24/2024
5:12 AM | ProQR Therapeutics (Filer)
| Form 424B5 | |
10/23/2024
5:18 AM | ProQR Therapeutics (Filer)
| Form 424B5 | |
10/10/2024
11:15 PM | ProQR Therapeutics (Filer)
| Form EFFECT | |
10/10/2024
3:18 PM | ProQR Therapeutics (Filer)
| Form 424B5 | |
09/30/2024
4:05 PM | ProQR Therapeutics (Filer)
| Form F-3
Registration statement for securities of certain foreign private issuers | |
08/08/2024
6:01 AM | ProQR Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/22/2024
3:19 PM | ProQR Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/09/2024
6:02 AM | ProQR Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/08/2024
7:07 AM | ProQR Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/23/2024
6:06 AM | ProQR Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/19/2024
6:06 AM | ProQR Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/13/2024
7:43 AM | ProQR Therapeutics (Filer)
| Form 20-F
Registration statement / Annual report / Transition report | |
03/13/2024
6:10 AM | ProQR Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/15/2024
6:46 AM | ProQR Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/14/2024
5:08 AM | ProQR Therapeutics (Subject)
VAN HERK INVESTMENTS B.V. (Filed by)
| Form SC 13G/A | |
02/09/2024
5:37 AM | ProQR Therapeutics (Subject)
VAN HERK INVESTMENTS B.V. (Filed by)
| Form SC 13G/A | |
01/19/2024
6:08 AM | ProQR Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/05/2024
6:08 AM | ProQR Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/08/2023
6:37 AM | ProQR Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/08/2023
6:37 AM | ProQR Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
